2007
DOI: 10.1016/j.ijcard.2006.08.045
|View full text |Cite
|
Sign up to set email alerts
|

Acute myocardial infarction during pregnancy successfully treated with primary percutaneous coronary intervention

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
4
0

Year Published

2007
2007
2014
2014

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 17 publications
(4 citation statements)
references
References 8 publications
0
4
0
Order By: Relevance
“…Percutaneous coronary intervention (PCI) is becoming the treatment of choice for revascularisation following AMI in pregnancy with reassuring reports on both its safety and efficacy. 911 Stent placement may be required depending on the findings during PCI. Pharmacologic management in the acute phase consists of anticoagulation with low-molecular-weight heparin and antiplatelet therapy with Aspirin and Thienopyridine derivatives such as Clopidogrel.…”
Section: Discussionmentioning
confidence: 99%
“…Percutaneous coronary intervention (PCI) is becoming the treatment of choice for revascularisation following AMI in pregnancy with reassuring reports on both its safety and efficacy. 911 Stent placement may be required depending on the findings during PCI. Pharmacologic management in the acute phase consists of anticoagulation with low-molecular-weight heparin and antiplatelet therapy with Aspirin and Thienopyridine derivatives such as Clopidogrel.…”
Section: Discussionmentioning
confidence: 99%
“…The most important points relevant to the management of patients with AMI during pregnancy are the timing of the delivery and drug treatment. A number of cases reporting successful PCI as a treatment of STEMI during pregnancy have been published [13,14]. Evidence-based treatment of these patients is difficult due to the lack of data from randomized controlled trials.…”
Section: Discussionmentioning
confidence: 99%
“…27], 28 and 31 β-blockers and nitrates can both be used in the management of these patients. 25, 29 and 31 The administration of nitrates in a pregnant patient needs to be monitored carefully as they may cause hypotension and tachycardia. 30 β1-selective blockers should be used in pregnant women, but it is important to remember that β-blockers are associated with intra-uterine growth restriction and hypoglycaemia.…”
Section: Treatmentmentioning
confidence: 99%